OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
А. С. Шкода, Vladimir А. Gushchin, Darya A. Ogarkova, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 938-938
Open Access | Times Cited: 27
А. С. Шкода, Vladimir А. Gushchin, Darya A. Ogarkova, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 938-938
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron
Yuchen Wei, Katherine Min Jia, Shi Zhao, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254777-e2254777
Open Access | Times Cited: 28
Yuchen Wei, Katherine Min Jia, Shi Zhao, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254777-e2254777
Open Access | Times Cited: 28
N-protein vaccine is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
Sevastyan O. Rabdano, Ellina Ruzanova, Anastasiya Evgenievna Vertyachikh, et al.
Journal of Infection (2024), pp. 106288-106288
Open Access | Times Cited: 5
Sevastyan O. Rabdano, Ellina Ruzanova, Anastasiya Evgenievna Vertyachikh, et al.
Journal of Infection (2024), pp. 106288-106288
Open Access | Times Cited: 5
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
On the issue of the safety of domestic vaccines against new coronavirus infection in medical workers
E. V. Zhukova, M. A. Mirskaya, T. П. Gotvyanskaya, et al.
Sanitarnyj vrač (Sanitary Doctor) (2024), Iss. 2, pp. 92-104
Closed Access | Times Cited: 4
E. V. Zhukova, M. A. Mirskaya, T. П. Gotvyanskaya, et al.
Sanitarnyj vrač (Sanitary Doctor) (2024), Iss. 2, pp. 92-104
Closed Access | Times Cited: 4
Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
Г. Т. Сухих, Т. В. Припутневич, Darya A. Ogarkova, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1804-1804
Open Access | Times Cited: 14
Г. Т. Сухих, Т. В. Припутневич, Darya A. Ogarkova, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1804-1804
Open Access | Times Cited: 14
Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14670-14670
Open Access | Times Cited: 14
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14670-14670
Open Access | Times Cited: 14
Functional Characteristics of Serum Anti-SARS-CoV-2 Antibodies against Delta and Omicron Variants after Vaccination with Sputnik V
Elizaveta I. Radion, Vladimir E. Mukhin, Alyona V. Kholodova, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1349-1349
Open Access | Times Cited: 8
Elizaveta I. Radion, Vladimir E. Mukhin, Alyona V. Kholodova, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1349-1349
Open Access | Times Cited: 8
Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Characterisation of the COVID-19 epidemic process in Moscow and search for possible determinants of the trends of the observed changes
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 4, pp. 267-284
Open Access | Times Cited: 5
Vladimir А. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 4, pp. 267-284
Open Access | Times Cited: 5
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 379-379
Open Access | Times Cited: 1
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 379-379
Open Access | Times Cited: 1
Evaluation of some parameters of the COVID-19 epidemic process and the epidemiological effectiveness of the use of the Gam-COVID–Vac vaccine among employees of two medical organizations in the Moscow region
A. A. Murzina, R. R. Ayvazyan, I. B. Kal’nin, et al.
Sanitarnyj vrač (Sanitary Doctor) (2023), Iss. 10, pp. 605-617
Closed Access | Times Cited: 4
A. A. Murzina, R. R. Ayvazyan, I. B. Kal’nin, et al.
Sanitarnyj vrač (Sanitary Doctor) (2023), Iss. 10, pp. 605-617
Closed Access | Times Cited: 4
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level
М. А. Годков, Darya A. Ogarkova, Vladimir А. Gushchin, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 90-90
Open Access | Times Cited: 5
М. А. Годков, Darya A. Ogarkova, Vladimir А. Gushchin, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 90-90
Open Access | Times Cited: 5
Vaccination as a protective factor for medical workers during the COVID-19 pandemic
E. A. Medvedeva, G. G. Maryin, О. А. Свитич, et al.
Science and Innovations in Medicine (2024) Vol. 9, Iss. 1, pp. 37-43
Open Access
E. A. Medvedeva, G. G. Maryin, О. А. Свитич, et al.
Science and Innovations in Medicine (2024) Vol. 9, Iss. 1, pp. 37-43
Open Access
Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers
E. A. Medvedeva, К. А. Зыков, Herman G. Marin, et al.
Annals of the Russian academy of medical sciences (2024) Vol. 79, Iss. 1, pp. 42-51
Closed Access
E. A. Medvedeva, К. А. Зыков, Herman G. Marin, et al.
Annals of the Russian academy of medical sciences (2024) Vol. 79, Iss. 1, pp. 42-51
Closed Access
The effect of vaccination against the COVID-19 on the course and outcomes of a new coronavirus infection: a retrospective analysis of laboratory and clinical indicators of hospitalized patients
A. A. Fomicheva, Nikolay Pimenov, Anna E. Tsygankova, et al.
Epidemiology and Infectious Diseases (2024) Vol. 29, Iss. 1, pp. 18-28
Open Access
A. A. Fomicheva, Nikolay Pimenov, Anna E. Tsygankova, et al.
Epidemiology and Infectious Diseases (2024) Vol. 29, Iss. 1, pp. 18-28
Open Access
RNAi-mediated inhibition of SARS-CoV-2: applications and challenges
Debosmita Sanyal, Binay Chaubey
Future Virology (2024) Vol. 19, Iss. 2-4, pp. 127-143
Closed Access
Debosmita Sanyal, Binay Chaubey
Future Virology (2024) Vol. 19, Iss. 2-4, pp. 127-143
Closed Access
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities
Jéromine Klingler, Shreyas Kowdle, Juan C. Bandrés, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jéromine Klingler, Shreyas Kowdle, Juan C. Bandrés, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Features of the COVID-19 epidemic process in the Moscow Region
А. Н. Каира, A. A. Murzina, G. G. Maryin
Sanitarnyj vrač (Sanitary Doctor) (2024), Iss. 5, pp. 329-342
Closed Access
А. Н. Каира, A. A. Murzina, G. G. Maryin
Sanitarnyj vrač (Sanitary Doctor) (2024), Iss. 5, pp. 329-342
Closed Access
Do we need coronavirus vaccination today?
K. K. Tikhomirova, С. М. Харит
Journal Infectology (2023) Vol. 15, Iss. 3, pp. 5-14
Open Access | Times Cited: 1
K. K. Tikhomirova, С. М. Харит
Journal Infectology (2023) Vol. 15, Iss. 3, pp. 5-14
Open Access | Times Cited: 1
Respuesta inmunitaria anti-SARS-CoV-2: Infección Natural vs. Vacunación
Maura J Petro Oropeza, Samuel Rodríguez Sanchez, Carlos Sanchez Fuentes, et al.
Revista Digital de Postgrado (2023) Vol. 12, Iss. 1
Open Access
Maura J Petro Oropeza, Samuel Rodríguez Sanchez, Carlos Sanchez Fuentes, et al.
Revista Digital de Postgrado (2023) Vol. 12, Iss. 1
Open Access
Methodical and Immunological Insights of Prime COVID-19 Vaccines
Wilson Pearl Evangeline, Sakthivelnathan Divyasri, C.V. Akshaya, et al.
Coronaviruses (2023) Vol. 5, Iss. 3
Closed Access
Wilson Pearl Evangeline, Sakthivelnathan Divyasri, C.V. Akshaya, et al.
Coronaviruses (2023) Vol. 5, Iss. 3
Closed Access
Immunization against COVID-19: A Comprehensive Review on the Leading Vaccines
Ananyaa Srinivasan, Vijaishree Rajesh, Dharani Thamilvanan, et al.
Coronaviruses (2023) Vol. 5, Iss. 4
Closed Access
Ananyaa Srinivasan, Vijaishree Rajesh, Dharani Thamilvanan, et al.
Coronaviruses (2023) Vol. 5, Iss. 4
Closed Access
SARS-CoV-2 y la vacunación: situación actual y futuros escenarios
Daniel Echeverri-De la Hoz, Alejandra García, Salim Salim, et al.
(2023)
Open Access
Daniel Echeverri-De la Hoz, Alejandra García, Salim Salim, et al.
(2023)
Open Access
